Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Filter
  • 1-10 of  56,725 نتائج ""Bone Density""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A novel effervescent formulation of oral weekly alendronate (70 mg) improves persistence compared to alendronate tablets in post-menopausal women with osteoporosis.

  • Authors : Giusti A; Rheumatology Unit, Department of Musculoskeletal System, Local Health Trust 3, Via Missolungi 14, 16147, Genoa, Italy. .; Bianchi G

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/adverse effects ; Osteoporosis* ; Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/drug therapy

  • Source: Aging clinical and experimental research [Aging Clin Exp Res] 2021 Sep; Vol. 33 (9), pp. 2529-2537. Date of Electronic Publication: 2021 Jan 15.Publisher: Springer Country of Publication: Germany NLM ID: 101132995 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1720-8319

تفاصيل السجل

×
Academic Journal

Effects of anti-resorptive treatment on the material properties of individual canine trabeculae in cyclic tensile tests.

  • Authors : Frank M; Institute of Lightweight Design and Structural Biomechanics, TU Wien, Gumpendorfer Straße 7, 1060 Vienna, Austria. Electronic address: .; Grabos A

Subjects: Alendronate*/Alendronate*/Alendronate*/pharmacology ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/pharmacology; Animals

  • Source: Bone [Bone] 2021 Sep; Vol. 150, pp. 115995. Date of Electronic Publication: 2021 May 01.Publisher: Elsevier Science Country of Publication: United States NLM ID: 8504048 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل السجل

×
Academic Journal

Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study.

  • Authors : McCloskey EV; Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK. .; Centre for Integrated Research in Musculoskeletal Ageing (CIMA), Mellanby Centre for Bone Research, University of Sheffield, Sheffield, UK. .

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use ; Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/complications ; Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/drug therapy

  • Source: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل السجل

×
Academic Journal

Bone Mineral Densitometry Reporting: Pearls and Pitfalls.

  • Authors : Martineau P; Department of Radiology, 12359University of Manitoba, Winnipeg, Manitoba, Canada.; Morgan SL

Subjects: Bone Density*; Absorptiometry, Photon/Absorptiometry, Photon/Absorptiometry, Photon/*standards ; Osteoporosis/Osteoporosis/Osteoporosis/*diagnostic imaging

  • Source: Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes [Can Assoc Radiol J] 2021 Aug; Vol. 72 (3), pp. 490-504. Date of Electronic Publisher: SAGE Publications Country of Publication: United States NLM ID: 8812910 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل السجل

×
Academic Journal

Denosumab in chronic kidney disease: a narrative review of treatment efficacy and safety.

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/adverse effects ; Osteoporosis*/Osteoporosis*/Osteoporosis*/drug therapy ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/drug therapy

  • Source: Archives of osteoporosis [Arch Osteoporos] 2021 Jul 28; Vol. 16 (1), pp. 116. Date of Electronic Publication: 2021 Jul 28.Publisher: Springer Country of Publication: England NLM ID: 101318988 Publication Model: Electronic Cited Medium: Internet ISSN: 1862-3514

تفاصيل السجل

×
Academic Journal

Evaluation of care delivery by a novel multidisciplinary bone health clinic for patients at risk of glucocorticoid-induced osteoporosis.

  • Authors : Abdullah H; Faculty of Medicine, Department of Family Practice, University of British Columbia, Vancouver, BC, Canada.; Koller G

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/adverse effects ; Osteoporosis*/Osteoporosis*/Osteoporosis*/chemically induced ; Osteoporosis*/Osteoporosis*/Osteoporosis*/drug therapy

  • Source: Archives of osteoporosis [Arch Osteoporos] 2021 Jul 07; Vol. 16 (1), pp. 108. Date of Electronic Publication: 2021 Jul 07.Publisher: Springer Country of Publication: England NLM ID: 101318988 Publication Model: Electronic Cited Medium: Internet ISSN: 1862-3514

تفاصيل السجل

×
Academic Journal

Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis: A 2-Year Randomized Study.

  • Authors : Sølling AS; Department of Internal Medicine, Randers Regional Hospital, Randers, Denmark.; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use ; Osteoporosis*/Osteoporosis*/Osteoporosis*/drug therapy ; Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/drug therapy

  • Source: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Publisher: American Society for Bone and Mineral Research Country of Publication: United States NLM ID: 8610640 Publication Model:

تفاصيل السجل

×
Academic Journal

Incidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women With Osteoporosis in the Phase 3 Long-Term Odanacatib Fracture Trial.

  • Authors : Papapoulos S; Leiden University Medical Center, Leiden, The Netherlands.; Bone H

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use ; Hip Fractures*/Hip Fractures*/Hip Fractures*/drug therapy ; Hip Fractures*/Hip Fractures*/Hip Fractures*/epidemiology

  • Source: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Publisher: American Society for Bone and Mineral Research Country of Publication: United States NLM ID: 8610640 Publication Model:

تفاصيل السجل

×
Editorial & Opinion

Circulating sclerostin levels during denosumab discontinuation and the subsequent early or late zoledronate infusion.

Subjects: Bone Density Conservation Agents* ; Osteoporosis, Postmenopausal*; Bone Density

  • Source: Endocrine [Endocrine] 2021 Jul; Vol. 73 (1), pp. 223-225. Date of Electronic Publication: 2021 Mar 02.Publisher: Humana Press Country of Publication: United States NLM ID: 9434444 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل السجل

×
  • 1-10 of  56,725 نتائج ""Bone Density""